467 related articles for article (PubMed ID: 31757001)
1. Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.
Kusaczuk M
Cells; 2019 Nov; 8(12):. PubMed ID: 31757001
[TBL] [Abstract][Full Text] [Related]
2. The bile acid TUDCA and neurodegenerative disorders: An overview.
Zangerolamo L; Vettorazzi JF; Rosa LRO; Carneiro EM; Barbosa HCL
Life Sci; 2021 May; 272():119252. PubMed ID: 33636170
[TBL] [Abstract][Full Text] [Related]
3. A fluorescent analogue of tauroursodeoxycholic acid reduces ER stress and is cytoprotective.
Gavin J; Quilty F; Majer F; Gilsenan G; Byrne AM; Long A; Radics G; Gilmer JF
Bioorg Med Chem Lett; 2016 Nov; 26(21):5369-5372. PubMed ID: 27729186
[TBL] [Abstract][Full Text] [Related]
4. The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases.
Vang S; Longley K; Steer CJ; Low WC
Glob Adv Health Med; 2014 May; 3(3):58-69. PubMed ID: 24891994
[TBL] [Abstract][Full Text] [Related]
5. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.
Vandewynckel YP; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Verhelst X; Van den Bussche A; Raevens S; Van Steenkiste C; Van Troys M; Ampe C; Descamps B; Vanhove C; Govaere O; Geerts A; Van Vlierberghe H
Oncotarget; 2015 Sep; 6(29):28011-25. PubMed ID: 26293671
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of the tertiary bile acid TUDCA for the resolution of endoplasmic reticulum stress in intestinal epithelial cells.
Berger E; Haller D
Biochem Biophys Res Commun; 2011 Jun; 409(4):610-5. PubMed ID: 21605547
[TBL] [Abstract][Full Text] [Related]
7. Molecular and Cellular Effects of Chemical Chaperone-TUDCA on ER-Stressed NHAC-kn Human Articular Chondrocytes Cultured in Normoxic and Hypoxic Conditions.
Kusaczuk M; Naumowicz M; Krętowski R; Cukierman B; Cechowska-Pasko M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562298
[TBL] [Abstract][Full Text] [Related]
8. Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis.
Seyhun E; Malo A; Schäfer C; Moskaluk CA; Hoffmann RT; Göke B; Kubisch CH
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G773-82. PubMed ID: 21778463
[TBL] [Abstract][Full Text] [Related]
9. From dried bear bile to molecular investigation: A systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders.
Huang F; Pariante CM; Borsini A
Brain Behav Immun; 2022 Jan; 99():132-146. PubMed ID: 34601012
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on
Li J; Huang Z; Jin Y; Liang L; Li Y; Xu K; Zhou W; Li X
Curr Neuropharmacol; 2024; 22(8):1374-1390. PubMed ID: 37691227
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases.
Khalaf K; Tornese P; Cocco A; Albanese A
Transl Neurodegener; 2022 Jun; 11(1):33. PubMed ID: 35659112
[TBL] [Abstract][Full Text] [Related]
12. UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
Cabrera D; Arab JP; Arrese M
Handb Exp Pharmacol; 2019; 256():237-264. PubMed ID: 31236688
[TBL] [Abstract][Full Text] [Related]
13. Insights by which TUDCA is a potential therapy against adiposity.
Freitas IN; da Silva JA; de Oliveira KM; Lourençoni Alves B; Dos Reis Araújo T; Camporez JP; Carneiro EM; Davel AP
Front Endocrinol (Lausanne); 2023; 14():1090039. PubMed ID: 36896173
[TBL] [Abstract][Full Text] [Related]
14. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes.
Mališová L; Kováčová Z; Koc M; Kračmerová J; Stich V; Rossmeislová L
PLoS One; 2013; 8(12):e82086. PubMed ID: 24312631
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis.
Paridaens A; Raevens S; Devisscher L; Bogaerts E; Verhelst X; Hoorens A; Van Vlierberghe H; van Grunsven LA; Geerts A; Colle I
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117681
[TBL] [Abstract][Full Text] [Related]
17. The Taurine-Conjugated Bile Acid (TUDCA) Normalizes Insulin Secretion in Pancreatic β-Cells Exposed to Fatty Acids: The Role of Mitochondrial Metabolism.
Dos Reis Araujo T; Santiago D; Simões P; Guimarães F; Zoppi CC; Carneiro EM
Adv Exp Med Biol; 2022; 1370():293-303. PubMed ID: 35882804
[TBL] [Abstract][Full Text] [Related]
18. Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease.
Ramalho RM; Viana RJ; Low WC; Steer CJ; Rodrigues CM
Trends Mol Med; 2008 Feb; 14(2):54-62. PubMed ID: 18218342
[TBL] [Abstract][Full Text] [Related]
19. Tauroursodeoxycholic acid enhances the pre-implantation embryo development by reducing apoptosis in pigs.
Kim JS; Song BS; Lee KS; Kim DH; Kim SU; Choo YK; Chang KT; Koo DB
Reprod Domest Anim; 2012 Oct; 47(5):791-8. PubMed ID: 22151574
[TBL] [Abstract][Full Text] [Related]
20. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
